Business Context and Reporting Period
This Form 8-K Current Report was filed by AtriCure, Inc. on July 21, 2006, regarding events occurring on July 24, 2006. The filing addresses a significant change in the company's executive leadership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of CFO: Thomas J. Etergino resigned as Vice President and Chief Financial Officer, effective August 18, 2006.
- Interim Management: Until a successor is named, David J. Drachman, President and Chief Executive Officer, will oversee finance functions in collaboration with the controller.
- Reporting Structure: All finance functions will report directly to Mr. Drachman during the transition.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, outlook, or specific risk factors beyond the operational impact of the CFO's departure. Mr. Etergino is leaving to pursue other endeavors. A press release detailing the resignation is attached as Exhibit 99.1.
Investor Verification Checklist
- Confirm the timeline for the appointment of a permanent Chief Financial Officer.
- Review the attached press release (Exhibit 99.1) for additional context on the resignation.
- Monitor future filings for any impact on financial reporting or internal controls during the interim period.